Drug intelligence / Profile preview

ioversol

Development stage
Approved
Lead developer
Liebel-Flarsheim
Modality
Small Molecules
Administration
Intravenous, Intra-arterial, Intraarticular
01

Overview

Ioversol is a non-ionic, water-soluble, low-osmolar iodinated contrast agent used in diagnostic radiography. Developed by Mallinckrodt and currently marketed primarily under the brand name Optiray, it is indicated for a wide range of procedures including cerebral, coronary, and peripheral angiography, as well as computed tomography (CT) and urography. As a radiopaque agent, ioversol works by increasing the attenuation of X-rays in the body, allowing for the visualization of blood vessels and organs that are otherwise difficult to distinguish from surrounding tissues. Its non-ionic nature and low osmolality are designed to improve patient tolerability and reduce the risk of adverse reactions compared to older ionic contrast media.

Brand names
Optiray
Other names
碘佛醇N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodoisophthalamide

Beyond the preview

Go deeper on ioversol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ioversol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call